Health Care Equipment & Services

ASIC completes investigations into Humm Group’s Cards AU and commercial subsidiaries, finding governance gaps but no enforcement yet. Learn how the fintech is tightening controls and what it means for investors.

Fisher & Paykel Healthcare’s Q4 2025 update shows robust cash, 12% cash‑flow growth, and a 55% margin—fueling R&D, value‑based pricing, and strategic expansion in global healthcare markets.

Perennial ETF spots ResMed as a top health‑tech pick, noting its strong EBITDA growth, ESG focus, and growing reimbursement pathways that boost ROI for patients and investors.

Pro Medic Us Ltd’s minor ETF holdings reveal a med‑tech firm poised for telehealth growth, yet lagging ESG and margin metrics—watch its strategy for upside in a tightening market.

UnitedHealth Group ranks among the world’s most valuable firms, proving healthcare’s resilience and tech‑driven growth in a sector‑shifting economy.

Discover how Cigna Group’s 30th AGM will transform shareholder engagement with secure video‑conference voting, real‑time transparency, and easy access to FY‑2026 reports.

Boston Scientific’s strategic acquisitions fuse diagnostics with cell‑therapy delivery, boosting safety, efficacy, and workflow efficiency in the evolving biologics market.

Medtronic raises Q4 2026 dividend amid record revenue growth, underscoring robust earnings and strategic expansion for investors and patients alike.

Veeva Systems jumps 8% amid a resilient healthcare rally, beating the S&P downturn and attracting investors with its undervalued cloud‑based life‑science solutions.

UnitedHealth Group’s steady dividend growth, tighter medical‑care ratio, and ESG recognition position it for sustained investor confidence and value‑based care success.